Folgen
-
AUTM 'VCs Talk Back' Part 1 by Columbia Technology Ventures
-
Fehlende Folgen?
-
Panel discussion with Garrard Beeney (Partner and Co-Head of the Intellectual Property and Technology Group at Sullivan & Cromwell), Ian McClure (Director at the Office of Technology Commercialization at the University of Kentucky, and former IPXI), Phil Hartstein (President and CEO of Finjan), John Veschi (CEO of Marquis Technologies and Former CEO of Rockstar), and Jeff Sears (Associate General Counsel and Chief Patent Counsel at Columbia University) covering such questions as “What is ‘efficient infringement’ and how have the new patent laws changed the licensing landscape?” (minute 1), “Advice for startups who believe their IP is being infringed by large companies?” (minute 14), “Advice on patent strategies for tech startups, vs. biopharma startups?” (minute 19); “What advice would you give the new Presidential, Secretary of Commerce, and the Director of the USPTO about intellectual property policy over the next 4 years?” (minute 28).
-
Panel discussion between Sean Dalton (Partner at Highland Capital Partners), Joe Ellis (CEO and Co-Founder of vidRovr), Hemai Parthasarathy (Scientific Director of Breakout Labs, Thiel Foundation), Nina Tandon (CEO and Co-Founder of EpiBone), and Misti Ushio (CEO of TARA Biosystems). The first 35 minutes are largely introductions to each of the panelists, explaining their career paths that lead them to becoming entrepreneurs or investors. The next 45 minutes are a lively panel discussion answering questions such as “What role does IP play in starting a company” (minute 35), “how do license deals get negotiated and what are common terms, especially with university startups” (minute 50), “best practices for startups on how to build a cost-effective IP filing strategy” (minute 62); “why does IP have particularly important value at the beginning and end of a startup’s lifecycle?” (minute 65), “advice for students who want to be entrepreneurs and investors?” (minute 67).
-
Hear Jeffrey M. Sears, PhD, Chief Patent Counsel for Columbia University, present a patent law primer focusing on what you need to know to preserve patent protection for your inventions.
-
On March 4 2016, former U.S. Small Business Administration’s Associate Administrator Javier Saade held an informational session on federal Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) grants. This session offers insight into the requirements of these highly competitive programs and ways to get an edge when applying for these research grants.
-
Listen to a panel discussion with Jeff Sears (Columbia's Chief Patent Counsel), Ofra Weinberger (Director of Licensing, CTV) and Ron Katz, (Senior Technology Licensing Officer, CTV) to explore invention disclosure, patenting, and the technology commercialization process. moderated by Columbia WIN member Dr. Anjali Saqi, professor of Pathology and Cell Biology at Columbia University Medical Center.
-
Columbia Technology Ventures’ Executive Director Orin Herskowitz discusses the fast-changing and ever-growing world of patenting and licensing early-stage university technologies, including examples of scientific inventions, how patent decisions get made, and how license agreements are negotiated, both within Columbia and across the industry.
-
Featuring a discussion and Q&A with Carlo Rizzuto, operating principal of Versant Ventures, a leading healthcare investment firm investing across the sector at all stages, with an emphasis on early-stage investment in therapeutics. In this video Carlo discusses Versant Ventures’ new $300 million fund for investing in bioscience, as well as other recent exciting developments and trends in venture capital and healthcare investing.
-
While venture capital investment is on the rise, the number of start-ups has also exploded, and competition for VC dollars is fierce. In this podcast, John Lee, Matthew Cohen, Louis P. Berneman of Osage University Partners offer insight into the decision-making process for VC firms and shed light on what VC funding can do for your start-up.
-
Hear from three current and former federal officials who will offer insight into how the Obama Administration has made innovation a top priority and what this means for the future of entrepreneurship, inside and outside the government. Xavier Hughes (Chief Innovation Officer, U.S. Dept. of Labor), Cheryl Martin (former Acting Director of ARPA-E at the U.S. Dept. of Energy) and moderator and participant Javier Saade (former U.S. Small Business Administration’s Associate Administrator) as they share insights gleaned from their careers working in the public and private sectors, the paths that led them to working in the Obama administration, and their thoughts on the future of innovation and entrepreneurship going forward.
-
Hear Jeffrey M. Sears, PhD, Chief Patent Counsel for Columbia University, present a patent law primer focusing on what you need to know to preserve patent protection for your inventions.
-
Presenting a panel discussion with Marian Nakada (Johnson & Johnson Innovation – JJDC), Bob Silverman (Roche) and Steven Weinstein (Novartis Ventures), moderated by CTV’s executive director Orin Herskowitz. The conversation touches on the various ways Big Pharma & Biotech are using venture capital investing, regional innovation centers, joint ventures, university research sponsorship, and IP licensing to source their next blockbuster products (as well as generate equity returns). The panelists share their perspectives on venture capital investing strategies in biopharma, how to pitch strategic investors, the surge in biotech IPOs, hot research areas within biopharma, and best practices for establishing R&D partnerships between industry and academia.
-
Presenting a discussion and Q&A with Doug Cole, managing partner of Flagship Ventures, a life science venture fund with over $1.4 billion under management and a new $574 million fund devoted to early-stage therapeutics, health technologies and sustainability. In an interview with CTV’s Executive Director Orin Herskowitz, Doug discusses Flagship Ventures’ perspective on opportunities and challenges within the venture investment landscape, current trends, past experiences with early-stage investing, its VentureLabs Fellows program, and building a career as a venture capitalist.
-
Pull back the curtain and find out how your patent application might hold up under prosecution by the U.S. Patent and Trademark Office (“USPTO”). Columbia University’s Chief Patent Counsel Jeff Sears demonstrates a mock patent examination, showing how the USPTO looks for prior art, evaluates claims made in patent applications, and finally decides whether to award a patent.
